Regulation of A2A adenosine receptor expression and functioning following permanent focal ischemia in rat brain

Journal of Neurochemistry

Volumn 104, Issue 2, 2008, Pages 479-490

  Trincavelli, Maria L ^a   Melani, Alessia ^b,c   Guidi, Sara ^a   Cuboni, Serena ^a   Cipriani, Sara ^b   Pedata, Felicita ^b   Martini, Claudia ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

Author keywords

A2A adenosine receptors; Adenylyl cyclase pathway; Focal ischemia; G protein coupling; Rat brain; Receptor regulation

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR; ADENYLATE CYCLASE; GUANINE NUCLEOTIDE BINDING PROTEIN; LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN INJURY; BRAIN ISCHEMIA; CELL ACTIVATION; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVATION; HEMISPHERE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DENSITY; REGULATORY MECHANISM; UPREGULATION;

ADENOSINE; ANIMALS; ASTROCYTES; BEHAVIOR, ANIMAL; BRAIN; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MALE; MOTOR ACTIVITY; NEUROLOGIC EXAMINATION; PHENETHYLAMINES; RATS; RATS, WISTAR; RECEPTORS, ADENOSINE A2;

RATTUS;

EID: 37349124567     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04990.x     Document Type: Article

References (57)

1. Alousi A. A., Jasper J. R., Insel P. A. Motulsky H. J. (1991) Stoichiometry of receptor-Gs-adenylate cyclase interactions. FASEB J. 5, 2300 2303.
2. 1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation. Brain Pathol. 13, 440 451.
3. Benjelloun N., Renolleau S., Represa A., Ben-Ari Y. Charriaut-Marlangue C. (1999) Inflammatory responses in the cerebral cortex after ischemia in the P7 neonatal Rat. Stroke 30, 1916 1923.
4. Bona E., Aden U., Gilland E., Fredholm B. B. Hagberg H. (1997) Neonatal cerebral hypoxia-ischemia: the effect of adenosine receptor antagonists. Neuropharmacol. 36, 1327 1338.
5. 2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes. Glia 43, 190 194.
6. Dixon A. K., Gubitz A. K., Sirinathsinghji D. J., Richardson P. J. Freeman T. C. (1996) Tissue distribution of adenosine receptor mRNAs in the rat. Br. J. Pharmacol. 118, 1461 1468.
7. 2A receptors on metabotropic glutamate receptor 5 (mGluR5)-mediated effects in the striatum. J. Neurochem. 90, 1276 1279.
8. 2A-receptors. Glia 18, 2 60.
9. 2 dopamine receptors in rat striatum. Brain Res. Mol. Brain Res. 14, 186 195.
10. Franchetti P., Cappellacci L., Marchetti S., Trincavelli L., Martini C., Mazzoni M. R., Lucacchini A. Grifantini M. (1998) 2′-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies. J. Med. Chem. 41, 1708 1715.
11. Garcia J. H., Wagner S., Liu K. F. Hu X. J. (1995) Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 26, 627 634.
12. Gebicke-Haerter P. J., Christoffel F., Timmer J., Northoff H., Berger M. Van Calker D. (1996) Both adenosine A1- and A2-receptors are required to stimulate microglial proliferation. Neurochem. Int. 29, 37 42.
13. 35S]GTPgammaS binding to guanine-nucleotide-binding-proteins in human platelet membranes. Life Sci. 64, 1403 1413.
14. Gimenez-Llort L., Schiffmann S. N., Shmidt T. et al. (2006) Working memory deficits in transgenic rats overexpressing human adenosine A(2A) receptors in the brain. Neurobiol. Learn. Mem. 4, [Epub ahead of print].
15. Ginsberg M. D. Busto R. (1989) Rodent models of cerebral ischemia. Stroke 20, 1627 1642.
16. 1 receptor binding characteristics and mRNA levels during the development of acute renal failure in the rat. Neurochem. Int. 120, 947 953.
17. 1 receptors in hippocampus. Naunyn-Schmiedeberg's Arch. Pharmacol. 370, 270 278.
18. 1 receptors in DTT1-MF2 cells. Biochem. Pharmacol. 67, 421 426.
19. Heese K., Fiebich B. L., Bauer J. Otten U. (1997) Nerve growth factor (NGF) expression in rat microglia is induced by adenosine A2a-receptors. Neurosci. Lett. 231, 83 86.
20. Latini S. Pedata F. (2001) Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem. 79, 463 484.
21. 2A adenosine receptor gene: a 4.8-kb promoter-proximal DNA fragment confers selective expression in the central nervous system. Eur. J. Neurosci. 18, 1786 1796.
22. 2A adenosine receptors. Life Sci. 68, 1343 1350.
23. 2A receptor knockout mice. Br. J. Pharmacol. 141, 1006 1014.
24. von Lubitz D. K. (2001) Adenosine in the treatment of stroke: yes, maybe, or absolutely not? Expert Opin. Investig. Drugs 10, 619 632.
25. 2A receptor antagonists of the release of glutamate induced by ischemia in rat cerebrocortical slices. Neuropharmacol. 45, 201 210.
26. 2A adenosine receptors in platelets from patients affected by bipolar disorders under treatment with typical antipsychotics. J. Psych. Res. 40, 81 88.
27. Melani A., Pantoni L., Corsi C., Bianchi L., Monopoli A., Bertorelli R., Pepeu G. Pedata F. (1999) Striatal outflow of adenosine, excitatory amino acids, gamma-aminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion. Corrrelations with neurological deficit and histopathological damage. Stroke 30, 2448 2455.
28. 2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behaviour and ischemic brain damage induced by permanent focal ischemia in the rat. Brain Res. 959, 243 250.
29. 2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia. Brain Res. 1073-1074 : 470 480.
30. de Mendonca A., Sebastiao A. M. Ribeiro J. A. (2000) Adenosine: does it have a neuroprotective role after all? Brain Res. Brain Res. Rev. 33, 258 274.
31. 2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats. Neuroreport 9, 3955 3959.
32. 11C-MPDX as an indicator of severe cerebral ischemic insult. J. Nucl. Med. 44, 1839 1844.
33. Narumiya S., Ohno M., Tanaka N., Yamano T. Shimada M. (1998) Enhanced expression of full-length TrkB receptors in young rat brain with hypoxic/ischemic injury. Brain Res. 797, 278 286.
34. Nishizaki T., Nagai K., Nomura T. et al. (2002) A new neuromodulatory pathway with a glial contribution mediated via A(2a) adenosine receptors. Glia 39, 133 147.
35. Ostrom R. S., Post S. R. Insel P. A. (2000) Stoichiometry and compartimentation in G protein-coupled receptor signalling: implication for therapeutical interventions involving Gs. JPET 294, 407 412.
36. Pearson T., Currie A. J., Etherington L. A., Gadalla A. E., Damian K., Llaudet E., Dale N. Frenguelli B. G. (2003) Plasticity of purine release during cerebral ischemia: clinical implications? J. Cell. Mol. Med. 7, 362 375.
37. 2A receptors in ischemia. Ann. N. Y. Acad. Sci. 939, 74 84.
38. 2A receptors in neuroprotection of dopaminergic neurons. Neurol. 61, S49 S50.
39. 2A receptor antagonism in cerebral ischemia. Neurol. Res. 27, 169 174.
40. 2A adenosine receptor antagonists on cerebral ischemic injury in the gerbil. Brain Res. 705, 79 84.
41. 2A receptor antagonists prevent the increase in striatal glutamate levels induced by glutamate uptake inhibitors. J. Neurochem. 89, 152 156.
42. 2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possibile relevance to neuroprotective interventions in neurodegenerative diseases of the striatum. J. Neurosci. 22, 1967 1975.
43. 2A receptor antagonists as neuroprotective agents. Curr. Med. Chem. Central Nervous System Drugs. 4, 35 45.
44. Pugliese A. M., Latini S., Corradetti R. Pedata F. (2003) Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors. Br. J. Pharmacol. 140, 305 314.
45. Ribeiro J. A., Sebastiao A. M. de Mendonca A. (2003) Participation of adenosine receptors in neuroprotection. Drug News Perspect. 16, 80 86.
46. Rosi S., McGann K., Hauss-Wegrzyniak B. Wenk G. L. (2003) The influence of brain inflammation upon neuronal adenosine A2B receptors. J. Neurochem. 86, 220 227.
47. Salomon Y. V. (1979) Adenylate cyclase assay, in Advances in Cyclic Nucleotide Research (Brooker G., Greengard P. Robinson G. A., eds Vol. 10, pp. 35 55. Raven Press, New York.
48. 2A receptor stimulation potentiates nitric oxide release by activated microglia. J. Neurochem. 95, 919 929.
49. 2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J. Neurochem. 57, 1062 1067.
50. 1 adenosine receptors in the rat hippocampus following transient forebrain ischemia. Neurosci. 114, 547 556.
51. Tanaka K. (2001) Alteration of second messengers during acute cerebral ischemia-adenylyl cyclase, cyclic AMP-dependent protein kinase, and cyclic AMP response element binding protein. Prog. Neurobiol. 65, 173 207.
52. 2B adenosine receptor functioning by tumour necrosis factor a in human astroglial cells. J. Neurochem. 91, 1180 1190.
53. Tyson G. W., Teasdale G. M., Graham D. I. McCulloch J. (1984) Focal cerebral ischemia in the rat: topography of hemodynamic and histopathological changes. Ann. Neurol. 15, 559 567.
54. 2A receptor agonist and antagonist. Eur. J. Pharmacol. 287, 295 302.
55. Wardas J. (2002) Neuroprotective role of adenosine in the CNS. Pol. J. Pharmacol. 54, 313 326.
56. 3 receptor-induced CCL2 synthesis in cultured mouse astrocytes. Glia 46, 410 418.
57. Zuchora B., Turski W. A., Wielosz M. Urbanska E. M. (2001) Protective effect of adenosine receptor agonists in a new model of epilepsy-seizures evoked by mitochondrial toxin, 3-nitropropionic acid, in mice. Neurosi. Lett. 305, 91 94.